An active tryptic fragment of hydrogenase 2 from Escherichia coli has been isolated from the periplasmic face of the cytoplasmic membrane, and the large and small subunits N-terminally sequenced. The large subunit is encoded by the hybC gene and shows no N-terminal processing, other than removal of the initiator methionine during its biosynthesis. Both N-terminal and the subsequent internal trypticfragment amino acid sequence indicate that the small subunit is neither encoded by hybA, a gene previously identified as encoding the small subunit [Menon et al. (1994) J. Bacteriol. 176, 4416Ϫ4423], nor any of the remaining genes in the hyb operon. Genome sequence analysis revealed the presence of an open reading frame which could potentially encode the peptide sequences of the proteolysed small subunit. The gene, designated hyb0, lies directly upstream of, and is separated by two nucleotides from, the start of the hybA gene. Hyb0, which shares an approximate 40% identity with other hydrogenase small subunit amino acid sequences, is synthesised with an N-terminal signal sequence containing a twin-arginine motif which is probably required for export of the enzyme. In the mature enzyme the small subunit is proteolytically cleaved after Ala37. Immunological analysis of strains overproducing either recombinant Hyb0 or HybA using antibodies specific for hydrogenase 2, readily identified Hyb0 as the small subunit. In a pleiotropic hypB mutant, which is unable to insert nickel into the active site, both the large and small subunits accumulate as unprocessed, soluble forms, consistent with the two subunits being assembled and processed in a coordinated manner during biosynthesis.
, suggesting that hydrogenase 1 may display a more complex structure in vivo.
Hydrogenase 3 forms a loose association with the molybdoenzyme formate dehydrogenase-H on the cytoplasmic face of the cytoplasmic membrane, where they collectively make up the formate hydrogenlyase complex [9] . Hydrogenase 3 is encoded by an operon (hyc) located at 58 min on the E. coli genome, which is composed of nine open reading frames hycABCDEF-GHI [4, 10] . The HycE gene encodes the nickel-containing large subunit. A hydrogenase-3 small subunit analogue has not been identified but the HycG protein could be a candidate. Of the other hyc gene products, only HycA and HycI have been characterised. HycA has a role in transcriptional regulation. HycI is a protease involved in post-translational processing of HycE.
Hydrogenase 2 was purified as an active tryptic fragment from the membranes of anaerobically grown, wild-type cells. The proteolysed fragment has a structure similar to that of hydrogenase 1 comprising two 61-kDa large subunits and two 31-kDa small subunits. Subsequent immunological analyses revealed that the trypsin treatment apparently left the large subunit untouched while about 5 kDa was lost from the small subunit [3] . An operon (hyb), believed to encode hydrogenase 2, has been cloned and sequenced [11] . The operon, present at 65 min on the E. coli chromosome, is composed of seven open reading frames hybABCDEFG. From the predicted sequences, hybC clearly encodes the hydrogenase-2 large subunit. HybB, like the hyaC gene product, has sequence similarity to b-type cytochromes. Surprisingly, none of the open reading frames encode As pQE70, hybO this study pFS77
As pQE70, hybA this study a polypeptide of clear identity to any of the previously described small subunits of [NiFe] hydrogenases. It was suggested that HybA, an Fe-S protein with an N-terminal signal sequence, may represent an unusual small subunit [11] . In this communication, we show that the small subunit of hydrogenase 2 is encoded by a hitherto unsuspected gene, designated hyb0, which is directly upstream of hybA. We also show that the small subunit accumulates in a soluble precursor form in a hypB mutant which is pleiotropically unable to insert nickel into the large subunits of E. coli hydrogenases.
MATERIALS AND METHODS
Bacterial strains. The E. coli strains and plasmids employed in this study are listed in Table 1 .
Growth of bacteria and preparation of subcellular fractions. Anaerobic growth of E. coli was in CR-fumarate medium [12] , which increases the level of active hydrogenase 2 [13] . Anaerobic growth was accomplished in capped aspirator jars filled almost to the top. Strains carrying plasmids were grown aerobically in Luria-Bertani medium at 37°C.
For subcellular fractionation of cells, the procedure of Ballantine and Boxer [14] was followed. Cultures were harvested by centrifugation at 7000 g, 4°C, for 15 min, the cell pellet was washed twice with ice-cold 100 mM potassium phosphate, pH 7.0, and resedimented as described above. Washed cells were either stored as pellets at Ϫ20°C, or resuspended in 50 mM Tris/ HCl, pH 7.5, 100 mM KCl, 1 mM benzamidine/HCL, 1 mM MgSO 4 . A crystal of deoxyribonuclease I (Sigma) was added to this, and the cells were broken by passage through a French pressure cell (2100 Pa). The crude cell extract was obtained after the removal of unbroken cells and cellular debris by a short centrifugation step (20 000 g, 4°C, for 20 min). Membrane and soluble protein fractions were prepared from the crude cell extract by a further centrifugation step of 150 000 g for 90 min at 4°C. Membrane extracts were washed once with 50 mM Tris/ HCl, pH 7.5, 250 mM KCl, and resuspended to a final protein concentration of 10 mg/ml in 50 mM Tris/HCl, pH 7.5.
Sphaeroplast formation. E. coli sphaeroplasts were prepared as described by Osborn et al. [15] . Sphaeroplasts were resuspended in 50 mM Tris/HCl, pH 7.5, 0.5 M sucrose to a final protein concentration of 4 mg/ml. If required, trypsin (Sigma) was added to a final concentration of 0.025% or 0.2 % (by mass) sphaeroplast protein concentration. Aliquots were withdrawn at regular time intervals and the reaction stopped by the addition of soybean trypsin inhibitor (Sigma) to a final concentration of 0.5% (by mass). Sphaeroplasts were separated from the solubilised protein fraction by centrifugation at 20 000 g for 10 min at 4°C. Hydrogenase and β-galactosidase activities in the soluble fraction were assayed as described below. Total enzyme activities were measured by sonication of sphaeroplasts followed by centrifugation (20000 g for 10 min at 4°C). Triton X-100 was added to the supernatant to a final concentration of 0.01 %, the sample centrifuged again and the supernatant assayed for hydrogenase and β-galactosidase activities.
Enzyme assays. Hydrogenase-uptake activity was assayed spectrophotometrically as the H 2 -dependent reduction of oxidised benzyl viologen at 600 nm in anaerobic cuvettes as described by Ballantine and Boxer [14] . Samples were analysed in duplicate and the mean values displayed less than 10% deviation.
β-Galactosidase activity was measured by the method described by Miller [16] . Each assay was performed in triplicate and the average result calculated; values rarely differed from the mean by more than 15%.
Purification of hydrogenase 2 tryptic derivative. Two purification protocols were employed in the isolation of hydrogenase 2: the purification procedure exactly as described by Ballantine and Boxer [3] and a modified version described below. Washed cell paste of anaerobically growth E. coli (25 g ) was resuspended in 25 ml 50 mM Tris/HCl, pH 7.5, 100 mM KCl, 1 mM benzamidine, 10 µg/ml deoxyribonuclease I, 0.1 % (mass/ vol.) 2-mercaptoethanol, broken, and cell membranes prepared as described. Hydrogenase 2 activity was released from the membrane by the addition of trypsin (Sigma) to a final concentration of 2.5 % (mass/vol.) membrane protein followed by incubation for 1 hour at 30°C. The reaction was stopped by the addition of soybean trypsin inhibitor (Sigma) to a final concentration of 5% (mass/vol.). Membrane residue was removed by centrifugation at 4°C for 90 min at 150 000 g and the resultant supernatant was loaded onto a DEAE-Sepharose Cl 6B column (11.5 cmϫ4.5 cm) equilibrated with 50 mM Tris/HCl, pH 7.5, 0.1 % (mass/vol.) 2-mercaptoethanol. After extensive washing, bound hydrogenase 2 activity was eluted in a single peak by application of a linear 0Ϫ200 mM KCl gradient (1000 ml). Hydrogenase-containing fractions were pooled and (NH 4 ) 2 SO 4 was added to a final concentration of 0.5 M. The sample was then applied to a 5-ml FPLC-linked phenyl-Superose column, which had been equilibrated with 50 mM Tris/HCl, pH 7.5, 0.5 M (NH 4)2SO4, 5 mM benzamidine, 0.1 % (mass/vol.) 2-mercaptoethanol, and proteins were eluted with a linear gradient (30 ml) of 0.5Ϫ0M (NH 4 ) 2 SO 4 . Hydrogenase activity eluted as a single peak at 0M (NH 4 ) 2 SO 4 . The active fractions were pooled and concentrated to a volume of 0.5 ml using a Centricon-10 concentrator (Amicon). The concentrate was applied to an FPLC-linked Superose 12 gel-filtration column which had been previously equilibrated with 50 mM Tris/HCl, pH 7.5, 250 mM NaCl, 5 mM benzamidine, 0.1 % (mass/vol.) 2-mercaptoethanol, and proteins were eluted in the same buffer. The hydrogenase-containing fractions were pooled and rapidly frozen as 50-µl beads in liquid nitrogen. Preparations typically yielded 250 µg hydrogenase 2 tryptic derivative with a specific H 2 /benzyl viologen oxidoreductase activity of 220 µmol benzyl viologen reduced · min Ϫ1 · mg Ϫ1 . Peptide isolation and amino acid sequencing. Hydrogenase 2 was purified by the method of Ballantine and Boxer [3] . 100 µg enzyme was subjected to SDS/PAGE, the small subunit excised from the gel and digested with trypsin by the method described by Knopf et al. [17] . The resultant tryptic peptides were separated by reverse-phase HPLC using a Waters C 18 column. Amino acid sequencing of peptides and N-terminal amino acid sequencing of proteins was carried out as described by Rivers et al. [18] using a Beckman 470A gas-phase automatic peptide sequencer.
Polyacrylamide gel electrophoresis and Western immunoblot. Polyacrylamide gel electrophoresis in the presence of SDS was performed as described by Laemmli [19] using 10% or 12.5 % (mass/vol.) acrylamide, 0.4 % (mass/vol.) bisacrylamide. Immunoblotting of SDS/polyacrylamide gels was performed essentially as described by Towbin et al. [20] . After SDS/ polyacrylamide gel electrophoresis, proteins were transferred to Hybond-C nitrocellulose membranes (Amersham) using a BioRad Trans-blot cell. Immunoreactive proteins were detected with a rabbit anti-hydrogenase 2 serum (diluted 1:5000) coupled to the Promega ProtoBlot detection system (Promega).
Cloning and overexpression of hyb0 and hybA. The hyb0 gene was amplified from E. coli cells by PCR. The oligonucleotide primer targeted to the 5′ end of hyb0 had the sequence 5′-GGAATAACTATGCATGCCTGGAGAT-3′ and incorporated an engineered SphI recognition sequence. The primer targeted to the 3′ end of hyb0 had the sequence 5′-GCGCAGATCTCTCCC-CCGTGAGTCAGCGTTA-3′ and incorporated an engineered BglII recognition sequence. The PCR product was digested with SphI and BglII and integrated into pQE70 to give plasmid pFS75.
A strategy identical to that designed for the cloning of hyb0 was employed in the cloning of hybA. The hybA gone was amplified from E. coli cells by PCR. The synthetic oligonucleotide primer targeted to the 5′ end of hybA had the sequence 5′-GGA-GAATAAGCATGCACAGACGTAATTT-3′ and incorporated an engineered SphI recognition sequence. The primer targeted to the 3′ end of hybA had the sequence 5′-GCGCAGATCTT-GACTCATGATCGTCTCCTC-3′ and incorporated an engineered BglII site. The PCR product was digested with SphI and BglII before being integrated into the expression vector pQE70 to yield plasmid pFS77.
Both the hyb0 gene in pFS75 and the hybA gene in pFS77 were engineered such as to incorporate a polyhistidine tail onto the C-termini of the gene-products. DNA sequencing of the plasmids confirmed that the coding regions were correct and that the altered bases specified by the primers had been incorporated. pFS75 and pFS77 were transformed separately into the E. coli expression host M15 carrying plasmid pREP4 which expresses high levels of lac repressor. Overexpression of the cloned genes was obtained by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to exponentially growing cultures at a final concentration of 2 mM.
Recombinant DNA techniques and DNA sequencing. Isolation of plasmid DNA, restriction enzyme digests, modification, ligation, transformation and electrophoresis were essentially as described [21] . Nucleotide sequencing reactions of the cloned DNA in plasmids pFS75 and pFS77 were performed using the ABI PRISM Dye Terminator Cycle Sequencing kit and products were analysed using an ABI 373 DNA sequencer. The nucleotide sequences of both DNA strands were determined. Synthetic oligonucleotides were supplied by Gibco BRL.
DNA sequences were collated, compiled and analysed using the GCG package, Daresbury Laboratory Seqnet Facility. Protein sequences were analysed using the Pileup and Prettybox programmes, on the GCG package, Daresbury Laboratory Seqnet Facility.
RESULTS
Trypsin-mediated release of a soluble active fragment of hydrogenase 2 from membranes. The active preparation of hydrogenase 2 that has been previously described is a proteolysed derivative of the enzyme obtained from material solubilised from a membrane preparation following exposure to trypsin [3] . Fig. 1 . The active site of hydrogenase 2 faces the periplasm. Sphaeroplasts were incubated with trypsin and enzyme activities assayed as described in Materials and Methods. Hydrogenase activity released after incubation with 0.025% trypsin (᭹) or 2% trypsin (᭡). β-Galactosidase activity released after incubation with 0.025% trypsin (᭜) or 2% trypsin ). Enzyme activities are expressed relative to the total enzyme activities determined after disruption of sphaeroplasts as described in Materials and Methods.
This preparation contains a large subunit of 61 kDa which is electrophoretically indistinguishable from the large subunit present in the membrane-bound mature enzyme as revealed by Western immunoblot analysis. The second polypeptide of the trypsin-solubilised preparation, the small subunit, has an apparent molecular mass of 30 kDa and is derived from a subunit of apparent molecular mass 35 kDa, which is part of the membrane-bound enzyme [3] . It appears that the active fragment is released from the membrane following trypsin cleavage of the small subunit of the enzyme. No information is available regarding other polypeptides that may be associated with the mature, membrane-bound enzyme. Advantage can be taken of the trypsin-mediated release of the hydrogenase 2 derivative to establish the location of this portion of the enzyme at the cytoplasmic membrane. Treatment of sphaeroplasts with trypsin over 60 min was sufficient to release approximately 40% of the total hydrogenase (H 2 :benzyl viologen oxidoreductase) activity (Fig. 1) . That this activity was that of the hydrogenase 2 trypsin derivative was established by the immunoprecipitation of all of this activity with antibodies specific for hydrogenase 2. The immunoprecipitated enzyme, as anticipated, comprised the apparently mature large subunit and the smaller 31-kDa derivative of the small subunit. A control measurement indicated that there was little breakage of sphaeroplasts over the incubation period and that the hydrogenase release was dependent on the presence of trypsin. Hydrogenase 2 not released by trypsin during the experiment remained membrane-associated with the larger mature form of the small subunit (not shown). It is clear, therefore, that the large subunit and the major part of the small subunit of hydrogenase 2 is located at the periplasmic face of the cytoplasmic membrane. The small subunit could, therefore, have an important role in the anchoring of the enzyme to the periplasmic face of the membrane. Furthermore, this subunit, which is thought to be in extensive intimate contact with the large subunit [6] , may play a role in the translocation of the Ni-centre-containing and Fe-S-centre-containing enzyme to its effective periplasmic location.
Identification of the gene encoding the small subunit of hydrogenase 2. In order to assess whether N-terminal proteolytic processing, which is characteristic of periplasmically located proteins, had occurred for either the small or large subunits of the enzyme, and to attempt to locate the trypsin-sensitive sites of the membrane-bound small subunit, N-terminal amino acid sequencing was carried out on both the subunits present in the isolated hydrogenase-2-active derivative. The N-terminal amino acid sequence of the large subunit was exactly as predicted from the DNA sequence of the hybC gene, after removal of the Nterminal methionine, namely SQRITI. This confirmed that exposure to trypsin employed for the release of the enzyme from the membrane in the purification did not cleave the N-terminus of the large subunit. Despite its effective periplasmic location, it is clear that no N-terminal processing of the large subunit has occurred during its biosynthesis and assembly. This agrees with the conclusions of others [11] that the large subunit is encoded by the hybC gene and that the proteolytic processing of this subunit associated with nickel acquisition is confined to the Cterminus [22] .
The N-terminal amino acid sequence obtained for the small subunit derivative of the hydrogenase 2 preparation was EM-AESVTNPQ. This sequence is not present in the putative gene products of any of the reading frames of the published sequence of the hybA gene which has previously been assigned as encoding the small subunit [11] . The small subunit of the hydrogenase 2 preparation was isolated following HPLC separation of the denatured enzyme. The small subunit was subjected to exhaustive trypsin digestion and several tryptic peptides, which were derived from internal parts of the subunit sequence, were isolated by reverse-phase HPLC. The sequences of two such peptides were NRPTFAYGR and LIHEHXER. Neither of these sequences correspond to any potential translated product of the hybA gene. This eliminates the possibility that the N-terminus of the small subunit is blocked and that the first sequence obtained was derived from a contaminant. It is clear, therefore, that the small subunit of hydrogenase 2 is not the product of the hybA gene as was previously suggested. Furthermore, it cannot be encoded by any other gene in the hybABCDEFG operon.
Reference to the E. coli genome sequence database [23] lead to the solution of the problem. A putative further, previously undetected, gene is present in the database immediately upstream of hybA. Comparison of the amino acid sequences of the possible products of this additional gene with the amino acid sequences determined for the small subunit of hydrogenase 2, confirmed that one of the reading frames for this gene encodes the small subunit of the enzyme. We designate this gene hyb0. The translated product of the hyb0 gene is a protein of 372 residues and molecular mass of 39652 Da (Fig. 2) .
Proteolytic processing and tryptic cleavage of the hydrogenase 2 small subunit. The two sequenced internal tryptic peptides are derived from adjacent regions located near the middle of the hyb0 primary translated gene product (Fig. 2) . The N-terminal sequence of the small subunit, however, corresponded to the sequence starting at Glu38. Tryptic cleavage cannot be responsible for this result since the amino acid residue predicted for the Nterminal side of Glu38 is not Lys or Arg but Ala. It has previously been suggested that the small subunits of Ni-Fe hydrogenases may be proteolytically processed at the N-terminus during biosynthesis and assembly [1] . The sequence analysis for hydrogenase 2 indicates that this is indeed the case.
A post-translational processing cleavage at Glu38 during biosynthesis would yield a mature, membrane-bound small subunit with a predicted molecular mass of 35 794 Da. This is very close to that estimated for the mature membrane-bound small subunit of 35 kDa [3] . A signal peptide of 37 residues is removed during biosynthesis. A motif RRXFXK has been iden- [23] , which lies upstream of the hybA gene. The nucleotides are numbered from the translational start of hyb0. The predicted amino acid sequence of Hyb0 is given in single-letter code below the DNA sequence. Possible ribosomebinding sites for hyb0 and hybA are indicated by a single line and the letters RBS above the sequence. Amino acid sequences which are underlined are those for which the sequence has been obtained experimentally from the tryptic small subunit fragment. The N-terminus of the mature Hyb0 is denoted in bold. Consensus signal sequence motifs [24] for Hyb0 and HybA are indicated. The arrows indicate putative sites for trypsin cleavage of the small subunit from the membrane. tified for several bacterial species, including E. coli, as a signal sequence that leads to the N-terminal cleavage of the signal peptides for periplasmically located proteins that contain prosthetic groups [24] ). The sequence RRDFMK occurs at residues 15Ϫ 20 in the deduced small subunit amino acid sequence (Fig. 2) . This is consistent with the periplasmic orientation of the small subunit and the presence of Fe-S centres within this subunit [6] .
Trypsinolysis, which liberates the active fragment of hydrogenase 2 from the membrane, cannot take place at the N-terminal part of the small subunit. The small subunit derivative present in the isolated trypsin-released enzyme has an apparent molecular mass of about 30 kDa. The site of trypsin cleavage which leads to the release of hydrogenase 2 from the membrane must be located at about residue 325 in order for about a 5-kDa Cterminal fragment to be removed. Three candidate trypsin cleav- age sites at Arg318 (cleavage at which would result in a trypsinised small subunit of molecular mass 30 421 Da), Lys321 (30 765 Da), and Lys327 (31 389 Da) are present in the polypeptide. Cleavage could occur at one of these sites specifically, or indeed at all three (Fig. 2) . The exact site of trypsin cleavage remains to be established.
Overexpression and immunological analysis of the small subunit and the hybA gene product. The coding sequence for hyb0 was amplified by PCR and the resulting fragment cloned into the C-terminal His-Tag vector pQE70 to produce plasmid pFS75 (see Materials and Methods). The His 6 -tagged small subunit (Hyb0) with the His 6 -tag at the C-terminus of the protein was overproduced in the E. coli strain M15/pREP4 transformed with pFS75. Overexpressed His 6 -tagged Hyb0 was produced to a high level following induction with IPTG (Fig. 3A) . The coding sequence for hybA was also amplified in a similar manner to that for the small subunit to give plasmid pFS77. A high level of expression of the C-terminally His-tagged HybA protein was obtained (Fig. 3 A) .
The His-tagged small subunit (Hyb0) and the His-tagged HybA fusion proteins were visualised as protein-staining bands on SDS/PAGE of 39 kDa and 35 kDa, respectively, which are consistent with the predicted molecular masses for the recombinant proteins of 40.7-kDa and 34.8-kDa. N-terminal sequence analyses of the recombinant proteins confirmed that neither was proteolytically processed in the expression system. The overexpressed proteins were each recovered as inclusion bodies in the pellet fraction following cell breakage and centrifugation. Western immunoblot analysis using antibodies specific for hydrogenase 2, of SDS/PAGE gels of crude extracts of cells overexpressing either Hyb0 or HybA, readily identified the hyb0 gene product as the small subunit of the enzyme (Fig. 3 B) . The antibodies did not cross react with hybA gene product even though large amounts were present on the gel. This independently confirms the identity of hyb0 as the small subunit gene and shows that the HybA polypeptide is not recognised by the anti-hydrogenase 2 serum.
The hyb operon. The result of this reassessment of the hyb operon is shown (Fig. 4) . The hyb0 gene is located directly upstream of the previously identified hybA gene within the hyb operon. The stop codon of hyb0 is separated from the putative start codon of hybA by 2 bp (Fig. 2) . A potential Shine-Dalgarno sequence is located 7 bp upstream of the hybA start within hyb0. It appears that hyb0 is an integral part of the hyb transcriptional unit under control of a promoter region upstream of hyb0. There is no further potential gene in the immediate upstream vicinity of hyb0.
The complete primary structure of Hyb0 demonstrates excellent similarity with previously identified hydrogenase small subunits (Fig. 5) . Hyb0 has 42.5% identity with Rhodobacter capsulatus hydrogenase small subunit, HupS, 41.1 % sequence similarity with Azotobacter vinelandii HoxK, 37.0% sequence identity with E. coli HyaA (hydrogenase 1 small subunit), and 36.8% identity with Desulphovibrio gigas HynB. The sequence comparison demonstrates convincingly that the small subunit contains three Fe-S centres, as has been shown by X-ray crystallography for the D. gigas hydrogenase [6] .
The hybA gene product shows some sequence similarity to hydrogenase small subunits to which it has been previously compared [11] . A database search revealed that HybA has 36% sequence identity with HmcB from D. vulgaris (Fig. 6) . HmcB, which has an N-terminal 'twin-arginine' signal sequence, is located at the periplasmic face of the cytoplasmic membrane to [25] ; hups, hupS gene product from R. capsulatus [26] ; hyaa, hyaA gene product of hydrogenase 1 from E. coli [7] ; hynb, hynB gene product from D. gigas [61; hyb0, small subunit of E. coli hydrogenase 2 [23] . Fig. 6 . Proteins with identity to HybA. Alignments were made using the Pileup and Prettybox programmes (Daresbury). hynb, hynB gene product from D. gigas [28] ; hyba, hybA gene product of E. coli hydrogenase 2 [11] ; nrfc, nrfC gene product of the nitrite reductase operon of E. coli [29] ; fdoh, H. influenzae fdoH gene product [30] . which it is thought to be located by a hydrophobic C-terminal region. The protein is believed to possess four Fe-S centres and is implicated in hydrogen-related electron transport in the bacterium [27] . The sequence similarity strongly suggests that HybA also contains four Fe-S centres. The HybA sequence contains RRNFIK, just two residues from its putative N-terminal Met, which strongly points to a periplasmic orientation for this protein [24] . It seems highly likely that HybA participates in the periplasmic electron-transferring activity of hydrogenase 2 during its catalytic turnover. The nrfC gene product, to which HybA is similar, is also a member of the '16Fe' ferredoxin superfamily and possesses the twin-arginine motif [24, 29] . Interestingly, the putative Haemophilus influenzae fdoH gene product shares sequence similarity with nrfC suggesting a similar Fe-S centre complement, but lacks the twin-arginine motif [30] .
Nickel-dependent processing of hydrogenase 2 small subunit. Several reports have indicated that the large subunit of Ni-Fe hydrogenases from a variety of sources undergoes proteolytic processing at its C-terminus associated with the acquisition of nickel during the biosynthesis of the enzyme [31Ϫ33]. The fate of the small subunit during biosynthesis has received little attention, largely due to the generally poor quality of antibodies available for this subunit. The work reported above has made available relatively large quantities of recombinant hydrogenase 2 small subunit. Use of this material has permitted positive identification of the hydrogenase 2 small subunit in SDS/PAGE analyses of crude preparations.
The hyp operon contains several genes that appear to catalyse cofactor acquisition by the hydrogenases during biosynthesis and are required for the active expression of all E. coli hydrogenases. Mutations in the hypB gene lead to the pleiotropic loss of all hydrogenase activities due to the inability of such mutants to insert nickel into the large subunit of the hydrogenases during biosynthesis [31, 34] . Western immunoblot analysis of the hydrogenase 2 small subunit region of an SDS/PAGE gel (Fig. 7A ) allows direct comparison with the mature (N-terminally processed), trypsin exposed (N-terminally processed and cleaved near the C-terminus by trypsin) and recombinant, his-tagged but unprocessed small subunit. It can be seen that the small subunit of hydrogenase 2 in this hypB deletion strain is unprocessed and is located exclusively in the soluble fraction.
Mutants defective in hypB can be restored to active hydrogenase sufficiency by growth in media supplemented with nickel (II) salts [31, 34] . Although the primary lesion in a hypB strain is the inability to insert nickel into the large subunit, the biosynthesis of the small subunit is disrupted in an apparently similar manner to the large subunit (Fig. 7 B) . Consistent with what has been shown previously for other hydrogenases, the large subunit is found in a non-proteolytically processed form in the soluble fraction of the mutant. This subunit becomes proteolytically processed and associated with the membrane when the mutant is grown in media supplemented with NiCl 2 . Consistent with the very large amount of inter-subunit contact anticipated between the large and small subunits in the mature active hydrogenase as suggested by X-ray crystallography [6] , it appears that the two subunits are assembled and processed in a coordinated manner during biosynthesis.
DISCUSSION
The DNA sequence of the structural operon hybABCDEFG for E. coli hydrogenase 2 was established by Menon et al. [33] . The purified enzyme, characterised as an H 2 :benzyl viologen oxidoreductase, was obtained following trypsin-dependent release from the membrane fraction and was characterised as a soluble tetramer comprising two large subunits of 61 kDa and two small subunits of 31 kDa [3] . That the hybC gene encoded the large subunit of the enzyme was established following the determination of some amino acid sequence for the large subunit [33] . The authors were less certain about the gene encoding the small subunit but suggested, following predicted sequence comparison, that the small subunit was encoded by hybA, noting, however, that the small subunit sequence appeared somewhat unusual. It is clearly established here that the small subunit of the enzyme is not encoded by hybA but by a previously overlooked gene, termed hyb0, within the operon but located immediately upstream hybA.
The location at the periplasmic face of the cytoplasmic membrane of that portion of hydrogenase 2 released from the membrane by trypsin exposure comprising the large subunit and a large portion of the small subunit has been established, confirming the results reported by Rodrigue et al. [35] . The large subunit is not subjected to N-terminal processing during biosynthesis but the small subunit is processed during assembly to release a 37-residue leader sequence from its N-terminus. The small subunit is clearly substantially exposed at the periplasmic surface since trypsin cleaves the subunit at one of three adjacent sites situated at about 50 amino acid residues from the C-terminus of the 335-residue mature polypeptide. The amino acid sequences of both the large and small subunits are closely similar to those of the D. gigas hydrogenase for which a three-dimensional structure has been obtained by crystallography [6] . In that structure, the three Fe-S-centre-containing small subunit makes extensive protein-protein contact with the Ni-FeϪcontaining large subunit. Molecular modelling (results not shown) indicates that a similar situation pertains for these subunits of E. coli hydrogenase 2. However, only the small subunit has the necessary leader sequence for membrane translocation. It is likely that the large subunit associates with the small subunit after acquiring their cofactors, prior to its translocation as a complex to the periplasmic face of the membrane. The membrane-bound hydrogenase of Alicaligenes eutrophus resembles E. coli hydrogenase 2 in that both the large and small subunits are exposed to the periplasm [36] . Removal of just the small subunit signal sequence prevented membrane translocation and activation of the enzyme complex in this organism [37] . The E. coli trimethylamine-Noxide reductase, a molybdoenzyme located in the periplasm, is also thought to fold and acquire its cofactor prior to membrane translocation via a Sec-independent export pathway [38] .
The clear identification of the hydrogenase 2 small subunit has allowed its study in a hypB mutant, which is defective in the ability to insert nickel into the large subunit during biosynthesis [31, 34] ). The small subunit, in its precursor form, is found exclusively in the soluble fraction in this mutant, as is the large subunit. Recovery of hydrogenase activity by growth with nickel chloride, leads to the mature forms of both subunits being located in the membrane fraction. This strongly supports a coordinated assembly and translocation process for these subunits. Brito et al. [39] also reported that the small subunit of the Rhizobium leguminosarum [NiFe] hydrogenase remained unprocessed in hypB mutant.
The precursor form of the small subunit incorporates a 37-residue N-terminal signal peptide. The signal peptide has an RRXFXK twin-arginine motif which has been implicated in effecting localisation of proteins containing prosthetic groups, to the periplasm or to the periplasmic face of the cytoplasmic membrane [24, 40] . The hybA gene product also possesses the RRXFXK motif and appears to associate with four Fe-S centres. It seems highly likely, therefore, that this protein is also located at the periplasmic face of the cytoplasmic membrane. The nature of the HybA protein places it as a strong candidate for being part of the membrane-bound hydrogenase 2 enzyme, probably serving as the electron acceptor from the small subunit. Further experimentation is clearly required to assess these suggestions. It seems clear, however, that hydrogenase 2 possesses two polypeptides with the twin-arginine motif. The possibility that HybA protein translocation and assembly is coordinated with that of the small and large subunits of the enzyme also remains to be addressed. The hyb operon is an example of an operon encoding more than one polypeptide with the twin-arginine motif, others are the E. coli and H. influenzae nap operons which encode periplasmic nitrate reductases [30, 41] . The cleavage site for the release of the signal peptide of the small subunit occurs at Ala37-Glu38 to the C-terminal side of a triple alanine sequence. This exact sequence is found at residues 26Ϫ29 in the HybA protein, strongly suggesting that the signal peptide cleavage occurs as for the small subunit, at this position.
The molecular enzymological characterisation of active hydrogenase 2 has been limited to the study of the soluble trypsinised derivative which catalyses H 2 :benzyl viologen oxidoreductase activity [3] . The hyb operon contains eight genes and the physiological function of the enzyme is to catalyse H 2 oxidation coupled to quinone reduction, probably linked to protonmotive force generation [42] . The proper characterisation of the active enzyme remains to be established. It is clear from the work of Ballantine and Boxer [3, 14] that hydrogenase 2 forms a protein complex, in Triton-X-100-dispersed membranes, of much lower electrophoretic mobility than the trypsin derivative. It is likely that the physiological complex includes HybA, HybB, a polypeptide with identity to the cytochrome-b γ-subunit of W. succinogenes hydrogenase [8] , along with the large and small subunits. It is less clear whether any of the other hyb gene products are also part of the active enzyme, indeed the hybD gene product appears to be a protease required for releasing a C-terminal peptide from the large subunit following nickel acquisition [10] . HybA appears to have no homologues in the gene clusters for the well characterised A. eutrophus or Bradyrhizobium japonicum hydrogenases [37, 43] . The hya operon encoding the closely related hydrogenase 1 of E. coli also lacks a HybA analogue. The present work offers a route to the further definition of the membrane-bound hydrogenase 2.
